Henry Schein

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Henry Schein and other ETFs, options, and stocks.

About HSIC

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. 

CEO
Stanley M. Bergman
CEOStanley M. Bergman
Employees
25,000
Employees25,000
Headquarters
Melville, New York
HeadquartersMelville, New York
Founded
1932
Founded1932
Employees
25,000
Employees25,000

HSIC Key Statistics

Market cap
8.41B
Market cap8.41B
Price-Earnings ratio
21.60
Price-Earnings ratio21.60
Dividend yield
Dividend yield
Average volume
1.76M
Average volume1.76M
High today
$70.23
High today$70.23
Low today
$68.90
Low today$68.90
Open price
$69.93
Open price$69.93
Volume
1.15M
Volume1.15M
52 Week high
$82.49
52 Week high$82.49
52 Week low
$60.56
52 Week low$60.56

HSIC News

Simply Wall St 9h
Henry Schein, Inc. Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Henry Schein's (NASDAQ:HSIC) stock up by 7.4% over the past three months. Given that the stock prices usually follow long-term business performance, we wonder i...

Henry Schein, Inc. Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?
Seeking Alpha 3d
Henry Schein announces CEO retirement

Health care solutions provider Henry Schein (NASDAQ:HSIC) (HSICV) announced on Tuesday the retirement of CEO Stanley Bergman at the end of 2025. Shares were -1...

Henry Schein announces CEO retirement
TipRanks 4d
Henry Schein CEO Stanley Bergman to retire - TipRanks

...

Henry Schein CEO Stanley Bergman to retire - TipRanks

Analyst ratings

65%

of 17 ratings
Buy
29.4%
Hold
64.7%
Sell
5.9%

More HSIC News

Benzinga 5d
This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
TipRanks 5d
Henry Schein downgraded to Neutral from Outperform at Baird

Baird downgraded Henry Schein (HSIC) to Neutral from Outperform with a price target of $72, down from $82. The firm cites concerns that the company’s biggest cu...

TipRanks 5d
Hold Rating on Henry Schein Amid Uncertainty Over Heartland Dental’s Potential Shift

Henry Schein, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeff Johnson from Robert W. Baird downgraded the rating o...

People also own

Based on the portfolios of people who own HSIC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.